Highlighted Publications
Jenkins MT, Chu YE, Franceski AM, Potts CR, Dubin R, Dickerson KM, Lee SC, Lu R, Welner RS, Ferrell PB. TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiation. Exp Hematol. 2025 Jan 22:104727. doi: 10.1016/j.exphem.2025.104727. Epub ahead of print. PMID: 39855457.
Heimlich, J. B., Bhat, P., Parker, A. C., Jenkins, M. T., Vlasschaert, C., Ulloa, J., Van Amburg, J. C., Potts, C. R., Olson, S., Silver, A. J., Ahmad, A., Sharber, B., Brown, D., Hu, N., van Galen, P., Savona, M. R., Bick, A. G., & Ferrell, P. B. (2024). Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation. Blood advances, 8(14), 3665–3678. https://doi.org/10.1182/bloodadvances.2023011445
Guess, T., Potts, C. R., Bhat, P., Cartailler, J. A., Brooks, A., Holt, C., Yenamandra, A., Wheeler, F. C., Savona, M. R., Cartailler, J. P., & Ferrell, P. B. (2022). Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia. Blood cancer discovery, 3(4), 316–329. https://doi.org/10.1158/2643-3230.BCD-21-0128
Sunthankar, K. I., Jenkins, M. T., Cote, C. H., Patel, S. B., Welner, R. S., & Ferrell, P. B. (2022). Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia. Leukemia, 36(4), 923–934. https://doi.org/10.1038/s41375-021-01487-9